ESLA

Estrella Immunopharma Inc. is a preclinical-stage biopharmaceutical firm located in Emeryville, California, dedicated to the development of innovative T-cell therapies for the treatment of blood cancers and solid tumors. The company is committed to addressing significant unmet medical needs in oncology by leveraging pioneering immunotherapy solutions that harness the body's immune system to fight cancer. With its focus on advanced research and development, Estrella is positioning itself as a critical player in the rapidly evolving landscape of cancer treatment.